INTRODUCTION
The inquiry into congenital heart surgery deaths in Bristol was widely publicised, became a political issue, and has had a profound effect on surgical practice in the United Kingdom. 1 Irrespective of the intense controversy generated by public reporting of mortality statistics in the American healthcare system, the Department of Health has insisted on a similar policy for cardiac surgical outcomes in the UK. 2 3 The Freedom of Information Act allows external bodies to access hospital statistics irrespective of whether they are complete, accurate, and substantiated. In these circumstances, any reporting agency has a responsibility to present factual information. Public reporting is particularly sensitive in the realm of paediatric mortality.
The Bristol inquiry used hospital episode statistics (HES) to compare outcomes with those of other congenital cardiac surgical units in the UK. 1 Spiegelhalter and colleagues subsequently debated the validity of this approach. 4 In 2004 the BMJ published a manuscript from the "Dr Foster" Unit at Imperial College, London, which described HES for mortality in congenital heart surgery. 5 The authors applied detailed statistical analysis to non-risk assessed HES data submitted by hospital clerical staff in most but not all UK congenital cardiac surgical centres. The clinical teams did not verify the data. The paper suggested that one unit, Oxford, had significantly higher mortality than the national average for open (with cardiopulmonary bypass) operations in infants and drew damaging conclusions. The information was widely published in the lay press. The Oxford unit questioned the results before publication, and the central cardiac audit database (CCAD) did so afterwards. A paper based on the CCAD had found no detectable difference in 30 day or one year survival between any of the 13 UK tertiary centres for congenital heart disease for the first year the database operated nationally. 6 In contrast, the Dr Foster paper suggested that Oxford had outlying mortality for open procedures between 1991 and 2002 in infants less than 1 year, with a probability of this happening by chance alone of less than 0.0002. 5 A multidisciplinary team therefore carried out an investigation to establish the difference between the mortality reported in the BMJ paper and carefully verified death rates for Oxford and other centres. We now report the findings of this investigation. number of cases. We reanalysed HES data provided by Aylin and colleagues for the specific two year period. The minimum dataset used by the CCAD includes date of death and is linked with the Office of National Statistics by using National Health Service number, to track mortality irrespective of place of death. In the CCAD, most cases with unknown outcomes were patients recorded as non-UK residents. These patients (averaging 8% but zero for Oxford and one other centre) were predominantly coded as private patients and lost to follow-up after leaving the UK. In order to have a longer time period for comparison of performance of centres, we also examined CCAD data for 2000-3 by investigation as the most up to date information available at the time (CCAD tracks outcomes at 12 months as well as 30 days after surgery and then validates it).
METHODS

Dr
The clinicians from all 13 UK centres continuously collected detailed information for the CCAD dataset on a prospective basis, and dedicated cardiac data managers from the hospital database at each centre submitted the data. The data are validated by annual multidisciplinary team visits to the clinical departments to confirm the accuracy of the information. This was a period when CCAD submissions had reached a high level of compliance and accuracy. Overall data provision for the CCAD dataset against benchmarked procedures was 96.8% at this time; completeness for individual fields ranged from 75% to 100%. When CCAD outcome data could not be recorded or verified (for instance when overseas patients had returned home and could not be traced) the data point was recorded as missing. We used outcomes for infants aged under 12 months who had surgery with cardiopulmonary bypass at the 11 centres in England to provide direct comparison with the HES data supplied by Dr Foster for the study period.
The findings presented are a simple comparison between HES and CCAD statistics for the number of patients operated on and mortality within 30 days. We also provide the CCAD recorded mortality statistics for all the centres between 1 April 2000 and 31 March 2003 compared with the national average as an update on the report of Gibbs and colleagues. 6 
RESULTS
In the study period 2000-2, CCAD data included between five and 147 more operations for each centre than the HES data (median 23). Compared with CCAD data, HES omitted between 5% and 38% (median 15%) of infants operated on in each centre (table) . The system used for reporting of postoperative deaths by HES resulted in a median shortfall of 40% (range 0-73%). In centre A, with the largest number of operations, 38% of all patients were missed by HES and only 27% of the total deaths were recorded. HES failed to track between 44% and 70% of deaths in four other centres (fig 1) . As a result, HES underestimated the mean 30 day hospital mortality at 4% compared with the CCAD derived figure of 8%.
In CCAD, between 1% and 23% of outcomes were missing in nine of the 11 English centres. Because of this, 30 day mortality could be higher in these centres. Oxford had the fewest open cardiac operations and provided the most complete statistics under direct comparison. From the CCAD outcome information, Oxford reported all deaths and had 98% and 100% completeness for all data points over the two year period. The 10% mortality for open heart surgery in infants for 2000-2 was not different from the mean for all centres (8%) (fig 1) . The missing deaths from other centres in HES led to the suggestion that Oxford had an outlying mortality because of the artefactually low national mortality produced from HES data. nine of the 11 centres in England. HES did not record operations on non-UK residents and detected only deaths that occurred in the hospital where the operation took place and during the same admission as the surgery. No validated data exist with which to compare HES before 2000, but we have no reason to suppose that it was more reliable before that time. Accordingly, the non-verified HES information was an unsuitable platform on which to base sophisticated statistical analysis. The Dr Foster paper did not present an accurate account of cardiac surgical activity or mortality in infants and consequently placed spurious and harmful conclusions in the public arena.
Strengths and weaknesses of the study This study provides a comprehensive appraisal of congenital cardiac surgical activity in the UK between 1 April 2000 and 31 March 2002 and highlights the substantial discrepancy between HES and CCAD. Aylin and colleagues stated that Oxford had excessive mortality on the basis of data collected between 1999 and 2000 and adjusted for procedure. Given that CCAD validated data were available only after 2000, we can refute that claim only from that time onwards. Equally, we did not adjust our data comparison for procedure. So far, none of the studies has attempted to stratify children by risk according to functional status or comorbidity.
The Thames Valley Strategic Health Authority review highlighted previous CCAD reviews of independently validated data, which show that all UK units produce similarly acceptable results. 7 CCAD data also showed that Oxford had the lowest mortality for non-cardiopulmonary bypass operations in infants aged under 12 months and was in the middle of the spectrum for all cardiac operations in this age group.
Although it provides the gold standard for collection of cardiac data in the UK, CCAD was imperfect in that some non-UK residents were lost to follow-up. This occurred particularly in high volume centres with overseas links. Some deaths within 30 days of operation could have been missed if the patients died abroad. CCAD now makes increasingly strenuous efforts to verify data at each congenital heart centre. Multidisciplinary CCAD team visits to all 13 UK centres guarantee a thorough approach for this system. Both cardiology and surgical teams are aware of the importance of accurate data submission. Providing an accurate description of a complex cardiac operation on an unusual heart defect can sometimes be very difficult, given the restrictions in database entry. Clinicians must enter the information of best fit. In contrast, clerical staff involved in HES submission are disadvantaged by less specialised knowledge and motivation to provide comprehensive and accurate data.
Strengths and weaknesses in relation to other studies Referencing their own publications, Aylin and colleagues suggested that HES data were of "significant quality to be used for analysis." 4 5 They have also stated that "patients where the outcome was unknown made little difference to the overall mortality." Information from our study indicates that these statements are wrong. Other authors have clearly shown the weaknesses and dangers of administrative databases when presenting cardiac mortality data in the public arena. 8 9 In a recent paper, Shahian and colleagues compared clinical and administrative data sources for report cards on coronary artery bypass graft surgery in hospitals in Massachusetts. 10 They found a 27.4% disparity in the volume of isolated coronary artery bypass graft surgery, a significant difference in observed in-hospital mortality, and an inappropriate classification of a centre as an outlier on the basis of inaccuracies in administrative data. Various statistical methods produced different risk adjusted mortalities. The administrative dataset was more prone to errors in coding of procedures and incorrect case numbers, non-standardised mortality end points, misalignment of data sources with intended use, absence of critical clinical variables, failure to differentiate comorbidities from complications, and inability to safely define outliers. In an editorial discussion of Shahian's paper, Ryan concluded that the public reporting of mortality statistics must be based on data of the highest quality derived from prospectively gathered, validated, and audited clinical sources and not from unverified administrative datasets. 10 11 Meaning of the study Publication of inaccurate statistics, particularly regarding paediatric deaths, detracts from rather than enhances public confidence. Data management requires resources, but most of the units were not funded to collect and validate data effectively. If mortality statistics are to be released, their quality must be beyond reproach. Precise database definitions, uniform training of data managers, and periodic external audit are essential. Adequate ascertainment of relevant deaths and complete recording of patient episodes are also needed.
The media are eager to publish leagues tables of performance. Dr Foster has pioneered this approach by providing newspapers with information for heart disease and other topical aspects of health care in return for a fee. Government agencies and the media increasingly tend to use administrative data for hospital profiling because they are inexpensive and available in a short time frame. Marshall and Spiegelhalter have questioned the reporting of performance indicators to provide explicit ranking of institutions. 12 Their key messages were that league tables are unreliable statistical summaries of performance and that institutions with smaller numbers of cases may be unjustifiably penalised or credited in comparison exercises. Any performance indicator should be reported with its associated statistical sampling variability.
Uncertainty about the public reporting of unit specific mortality statistics We believe the UK to be the first country to follow some American states by placing non-risk stratified statistics for cardiac surgical mortality in the public arena. 13 This was a Department of Health initiative in response to the Bristol inquiry, which also used HES. 4 Similar problems have now been experienced on both sides of the Atlantic. The public reporting of mortality statistics in isolation cannot increase the safety of cardiac surgery but may reduce mortality if the system discards high risk patients. We do not believe that surgeons wish to take this route, but many will follow their self preservation instinct. 14 In the United States, the tertiary referral centres with the greatest expertise often have the highest mortality because they treat the sickest patients. 10 11 13 Many other countries collect surgical outcome data to monitor and improve their hospitals' performance but will not divulge this information to the media. Given the problems with data quality, the imprecision of risk stratification models, and the confrontational agenda in the media, we question the value of placing mortality statistics in the public domain.
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